Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel S Key

Showing results (101-110 of 255) with videos related to

Pageof 26
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 29, 2019
Excessive breakthrough bleeding in haemophilia B patients on factor IX-albumin fusion protein prophylactic therapy: A single centre case seriesBrendan Kleiboer, Brenda Nielsen, Alica D Ma, et al.
Thrombosis Research|August 2, 2020
Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT studyAnton Ilich, Vaibhav Kumar, Michael Henderson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2021
Emicizumab reduces re-hospitalization for bleeding in acquired haemophilia ASheh-Li Chen, Patrick Ellsworth, Raj S Kasthuri, et al.
European Journal of Haematology|July 11, 2012
Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemiaRoni J Bollag, Meghan Sterett, Mark T Reding, et al.
Research and Practice in Thrombosis and Haemostasis|February 9, 2026
Relationships between bleeding assessment tools (ISTH-BAT, Self-BAT) and quality of life in patients with bleeding symptomsCallie Berkowitz, Supreet K Goraya, Angela M Stover, et al.
Thrombosis Research|October 16, 2020
Biomarker-enhanced VTE risk stratification in ambulatory patients with cancerJoseph R Shaw, Vaibhav Kumar, Ranjeeta Mallick, et al.
Leukemia & Lymphoma|April 11, 2017
Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohortDamon E Houghton, Nigel S Key, Neil A Zakai, et al.
Thrombosis and Haemostasis|August 23, 2020
Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United StatesRushad Patell, Shonali Midha, Stephen Kimani, et al.
The Oncologist|September 24, 2020
D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with CancerVaibhav Kumar, Joseph R Shaw, Nigel S Key, et al.
Journal of the American Society of Nephrology : JASN|January 9, 2010
High prevalence of sickle cell trait in African Americans with ESRDVimal K Derebail, Patrick H Nachman, Nigel S Key, et al.
Pageof 26

Showing results (101-110 of 255) with videos related to

Sort By:
Pageof 26
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 29, 2019
Excessive breakthrough bleeding in haemophilia B patients on factor IX-albumin fusion protein prophylactic therapy: A single centre case seriesBrendan Kleiboer, Brenda Nielsen, Alica D Ma, et al.
Thrombosis Research|August 2, 2020
Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT studyAnton Ilich, Vaibhav Kumar, Michael Henderson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 29, 2021
Emicizumab reduces re-hospitalization for bleeding in acquired haemophilia ASheh-Li Chen, Patrick Ellsworth, Raj S Kasthuri, et al.
European Journal of Haematology|July 11, 2012
Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemiaRoni J Bollag, Meghan Sterett, Mark T Reding, et al.
Research and Practice in Thrombosis and Haemostasis|February 9, 2026
Relationships between bleeding assessment tools (ISTH-BAT, Self-BAT) and quality of life in patients with bleeding symptomsCallie Berkowitz, Supreet K Goraya, Angela M Stover, et al.
Thrombosis Research|October 16, 2020
Biomarker-enhanced VTE risk stratification in ambulatory patients with cancerJoseph R Shaw, Vaibhav Kumar, Ranjeeta Mallick, et al.
Leukemia & Lymphoma|April 11, 2017
Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohortDamon E Houghton, Nigel S Key, Neil A Zakai, et al.
Thrombosis and Haemostasis|August 23, 2020
Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United StatesRushad Patell, Shonali Midha, Stephen Kimani, et al.
The Oncologist|September 24, 2020
D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with CancerVaibhav Kumar, Joseph R Shaw, Nigel S Key, et al.
Journal of the American Society of Nephrology : JASN|January 9, 2010
High prevalence of sickle cell trait in African Americans with ESRDVimal K Derebail, Patrick H Nachman, Nigel S Key, et al.
Pageof 26